• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Mpm Capital L.P.

BioCentury | Jan 18, 2020
Politics, Policy & Law

Final reg reduces numbers of biopharma companies subject to CFIUS reviews

A final rule reduces the number of biopharma companies that will be subject to CFIUS reviews
BioCentury | May 13, 2019
Finance

How ElevateBio plans to create portfolio of cell, gene therapy newcos with $150M MPM, F2-led round

Led by Alexion, bluebird veterans, ElevateBio launches to build internal manufacturing capabilities and spin out cell and gene therapy companies
BioCentury | Sep 14, 2018
Financial News

MPM, Versant launch gene therapy play Coda

BioCentury | Aug 17, 2017
Finance

Built to purpose

How build-to-buy deals are reaching an inflection point
BioCentury | Jan 15, 2007
Company News

SkyePharma, Blue Acquisition deal

BioCentury | May 20, 2002
Company News

GenPath board of directors update

BioCentury | May 13, 2002
Company News

Arriva board of directors update

BioCentury | Feb 19, 2002
Company News

Sention board of directors update

BioCentury | Aug 21, 2000
Company News

Xcyte board of directors update

Items per page:
1 - 10 of 11
Help Center
Username
Request Training
Submit Data Correction
Ask a Question